Téodor Danaila

Researcher

Lyon College

faculty

14 h-index 64 pubs 693 cited

Research Areas

Links

ORCID

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Téodor Danaila, a faculty member at Lyon College, focuses on neurological disorders, particularly Parkinson's disease mechanisms and treatments. His research also encompasses genetic neurodegenerative diseases, cerebral palsy, and the therapeutic applications of botulinum toxin. Danaila's recent publication dates to 2025.

Metrics

h-index: 14
Publications: 64
Citations: 693

Selected Publications

Vieillissement normal et maladie de Parkinson : décrypter les changements neurophysiologiques affectant la marche (2025) DOI
Non-motor subtypes in candidates for subthalamic deep brain stimulation for Parkinson's disease (2025) DOI
Comment prendre en soins les personnes atteintes d’une maladie de Parkinson dans un service de Réanimation ? (2025) DOI
A comparison of electrophysiological microrecording versus automatic MR-based segmentation to determine subthalamic nucleus boundaries (2025) DOI
Deep Brain Stimulation in Classical Galactosemia: A Case‐Report (2025) DOI
A delphi consensus statement about French practical management of continuous apomorphine infusion in patients with Parkinson's disease and motor fluctuations (2025) DOI
Complications non motrices de la maladie de Parkinson : gestion des troubles cognitifs, de la dénutrition et des troubles urinaires (2025) DOI
Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies (2024) DOI
Deep brain stimulation for severe dystonia associated with Wilson disease: A prospective multicenter meta‐analysis of an N‐of‐1 trial (2024) DOI
Falsely reassuring impedance in a patient with deep brain stimulation: a case report (2024) DOI
Amantadine use in the French prospective NS-Park cohort (2024) DOI
Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial (2024) DOI
Motivational and cognitive predictors of apathy after subthalamic nucleus stimulation in Parkinson’s disease (2023) DOI
Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson’s disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial (2023) DOI
Beware of atypical apathy after STN stimulation (2022) DOI